Study to Investigate the Absorption, Metabolism and Excretion of Talampanel
- Study Title
- A Study to Investigate the Absorption, Metabolism and Excretion of Talampanel
- Teva Identifier
- TAL-MB-100
- ClinicalTrials.gov Identifier
- NCT00868361
- Study Status
- Terminated
- Trial Condition(s)
- Healthy
- Interventions
- Drug: Talampanel (non-radiolabeled), [14C] Talampanel
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Male
- Age group
- Adult
- Age Range
- 18 Years to 55 Years
- Trial Duration
- 05/01/2009 - 09/01/2009
- Phase
- Phase 1
